CHD2基因变异相关癫痫临床特点分析
Analysis of the clinical characteristics of epilepsy associated with CHD2 gene variation
Received date: 2021-12-31
Online published: 2023-02-16
冯帆 , 陈芳 , 孙素真 , 李鑫 , 刘学芳 , 赵彤 . CHD2基因变异相关癫痫临床特点分析[J]. 临床儿科杂志, 2023 , 41(1) : 48 -53 . DOI: 10.12372/jcp.2023.22e0007
Key words: CHD2 gene; epilepsy; clonic seizure; developmental retardation
[1] | Wilson MM, Henshall DC, Byrne SM, et al. CHD2-related CNS pathologies[J]. Int J Mol Sci, 2021, 22(2): 588. |
[2] | Cardoso AR, Lopes-Marques M, Oliveira M, et al. Genetic variability of the functional domains of chromodomains helicase DNA-Binding (CHD) proteins[J]. Genes (Basel), 2021, 12(11): 1827. |
[3] | Lamar KJ, Carvill GL. Chromatin remodeling proteins in epilepsy: lessons from CHD2-Associated epilepsy[J]. Front Mol Neurosci, 2018, 11: 208. |
[4] | Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy[J]. Epilepsia, 2014, 55 (4): 475-482. |
[5] | EuroEPINOMICS-RES Consortium. Electronic address: euroepinomics-RES@ua.ac.be; Epilepsy Phenome/Genome Project;et al, De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies[J]. Am J Hum Genet, 2017, 100(1): 179. |
[6] | Carvill GL, Heavin SB, Yendle SC, et al. Targeted Resequencing in Epileptic Encephalopathies identifies do novo mutations in CHD2 and SYNGAP1[J]. Nat Genat, 2013, 45(7): 825-830. |
[7] | Chénier S, Yoon G, Argiropoulos B, et al. CHD 2 haplo- insufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems[J]. J Neurodev Disord, 2014, 6(1): 9. |
[8] | Courage C, Houge G, Gallati S, et al. 15q26.1 Microdeletion encompassing only CHD2 and RGMA in two adults with moderate intellectual disability, epilepsy and truncal obesity[J]. Eur J Med Genet, 2014, 57(9): 520-523. |
[9] | Lund C, Brodtkorb E, ?ye A M, et al. CHD2 mutations in Lennox-Gastaut syndrome[J]. Epilepsy Behav, 2014, 33: 18-21. |
[10] | Thomas RH, Zhang LM, Carvill GL, et al. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures[J]. Neurology, 2015, 84(9): 951-958. |
[11] | Trivisano M, Striano P, Sartorelli J, et al. CHD2 mutations are a rare cause of generalized epilepsy with myoclonic-atonic seizures[J]. Epilepsy Behav, 2015, 51: 53-56. |
[12] | Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia, 2017, 58(4): 512-521. |
[13] | Zimmern V, Korff C. Status epilepticus in children[J]. Clin Neurophysiol, 2020, 37(5): 429-433. |
[14] | Carvill GL, Mefford HC. CHD2-Related Neuro-developmental Disorders[M]//Adam MP, Everman DB, Mirzaa GM, et al. GeneReviews?[Internet]. Seattle (WA): University of Washington: 1993-2022. |
[15] | Thomas RH, Zhang LM, Carvill GL, et al. CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures[J]. Neurology, 2015, 84(9): 951-958. |
[16] | Firth HV, Richards SM, Bevan AP, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources[J]. Am J Hum Genet, 2009, 84(4): 524-33. |
[17] | Galizia EC, Myers CT, Leu C, et al. CHD2 variants are a risk factor for photosensitivity in epilepsy[J]. Brain, 2015, 138(Pt 5): 1198-1207. |
[18] | Suls A, Jaehn JA, Kecskés A, et al. De novo loss-of-functionmutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome[J]. Am J Hum Genet, 2013, 93 (5):967-975. |
[19] | Chen J, Zhang J, Liu A, et al. CHD2-related epilepsy: novel mutations and new phenotypes[J]. Dev Med Child Neurol, 2020, 62(5): 647-653. |
[20] | Lebrun N, Parent P, Gendras J, et al. Autism spectrum disorder recurrence, resulting of germline mosaicism for a CHD2 gene missense variant[J]. Clin Genet, 2017, 92(6): 669-670. |
[21] | Veredice C, Bianco F, Contaldo I, et al. Early onset myoclonic epilepsy and 15q26 microdeletion: observation of the first case[J]. Epilepsia, 2009, 50(7): 1810-1815. |
[22] | Trivisano M, Striano P, Sartorelli J, et al. CHD2 mutations are a rare cause of generalized epilepsy with myoclonic-atonic seizures[J]. Epilepsy Behav, 2015, 51: 53-56. |
[23] | Singh N, Ritaccio A. Juvenile myoclonic epilepsy mimic associated with CHD2 gene mutation[J]. Epilepsy Behav Rep, 2020, 13: 100355. |
[24] | Carvill GL, Heavin SB, Yendle SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1[J]. Nat Genet, 2013, 45(7): 825-830. |
[25] | Cardoso AR, Lopes-Marques M, Oliveira M, et al. Genetic variability of the functional domains of chromodomains helicase DNA-binding (CHD) proteins[J]. Genes (Basel), 2021, 12(11): 1827. |
[26] | Galizia EC, Myers CT, Leu C, et al. CHD2 variants are a risk factor for photosensitivity in epilepsy[J]. Brain, 2015, 138(Pt 5): 1198-1207. |
[27] | Pinto AM, Bianciardi L, Mencarelli MA, et al. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation[J]. Brain Dev, 2016, 38(6): 590-596. |
[28] | Lebrun N, Parent P, Gendras J, et al. Autism spectrum disorder recurrence, resulting of germline mosaicism for a CHD2 gene missense variant[J]. Clin Genet, 2017, 92(6): 669-670. |
[29] | Verhoeven WM, Egger JI, Knegt AC, et al. Absence epilepsy and the CHD2 gene: an adolescent male with moderate intellectual disability, short-lasting psychoses, and an interstitial deletion in 15q26.1-q26.2[J]. Neuropsychiatr Dis Treat, 2016, 12: 1135-1139. |
[30] | 旷小军, 张晓, 宁泽淑, 等. 颈部肌阵挛伴失神发作2例报告并文献复习[J]. 临床儿科杂志, 2021, 39(5):366-369. |
[31] | Kessler SK, McGinnis E. A practical guide to treatment of childhood absence epilepsy[J]. Paediatr Drugs, 2019, 21(1): 15-24. |
/
〈 |
|
〉 |